Advertisement

Allergic Disease

  • Manzoor M. Khan
Chapter

Introduction

The term allergy (from Greek allos, meaning “other,” and ergon, meaning “work”) was introduced in 1906 by von Priquet. Atopy (from Greek, meaning “out of place”) is also used to describe allergic disease. In 1919, a physician first reported allergy-related symptoms of transient asthma following blood transfusion. In the study, a response to horse dander suggested that an allergic reaction could be mediated by a factor in the blood. The passive transfer of a positive skin test performed by Prausnitz and Kustner in an experiment in 1921 led to a search to discover the substances responsible for allergic reaction. Until 1960 the focus was on several labile complexes in the serum rather than on one molecule, and it was assumed that antibodies were not involved in allergic reaction.

In 1965, Bennick and Johansson in Sweden reported a new class of immunoglobulin called IgND, and it was subsequently found that the levels of IgND were severalfold higher in allergic asthmatics than...

Keywords

Mast Cell Atopic Eczema Allergic Rhinitis Allergic Disease House Dust Mite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Bibliography

  1. Aberg N, Sundell J, Eriksson B, Hesselmar B. 1996. Prevalence of allergic disease in school children in relation to family history, upper respiratory tract infections and residential characteristics. Allergy. 51:232–237.PubMedGoogle Scholar
  2. Akdis CA, Blasker K. 1999. IL-10-induced anergy in peripheral T cells and reactivation by micro environmental cytokines: Two key steps in specific immunotherapy. FASEB J. 13:603–609.PubMedGoogle Scholar
  3. Akdis CA, Blaser K. 2003. Histamine in the immune regulation of allergic inflammation. J All Clin Immunol. 112:15–22.Google Scholar
  4. Akdis M, Blaser K, Akdis CA. 2005. T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention and treatment of allergic diseases. J All Clin Immunol. 116:9961–969.Google Scholar
  5. Alam R, Kampern G. 2002. Cytokines in allergic inflammation. J Clin All Immunol. 16:255–274.Google Scholar
  6. Annesi I, Oryszczyn M, Frette C, Neukirch F, et al. 1992. Total circulating IgE and FEV1 in adult men: An epidemiologic longitudinal study. Chest. 101:642–648.PubMedGoogle Scholar
  7. Annunziato F, Cosmi L, Galli G, Beltrame C, et al. 1999. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leukoc Biol. 65:691–699.PubMedGoogle Scholar
  8. Bach J-F. 2002. The effects of infections on susceptibility to autoimmune and allergic diseases. NEJM. 347:911–920.PubMedGoogle Scholar
  9. Barnes PJ. 1991. Neuropeptides and asthma. Am Rev Respir Dis. 143:S28–S32.PubMedGoogle Scholar
  10. Barnes PJ. 1999. Anti-IgE antibody therapy for asthma. NEJM. 341:2006–2008.PubMedGoogle Scholar
  11. Barnes PJ. 2000. New directions in allergic diseases: Mechanism based anti-inflammatory therapies. J All Clin Immunol. 106:5–16.Google Scholar
  12. Beasley R, Burgess R, Crane J, Pearce N, et al. 1993. Pathology of asthma and its clinical implications. J All Clin Immunol. 92:148–154.Google Scholar
  13. Bisset LR, Schmid-Grendelmeier P. 2005. Chemokines and their receptors in the pathogenesis of allergic asthma: Progress and perspective. Curr Opin Pulm Med. 11:35–42.PubMedGoogle Scholar
  14. Boulet LP, Chapman KR, Cote J, Kalra S, et al. 1997. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am J Respir Crit Care Med. 155:1835–1840.PubMedGoogle Scholar
  15. Bousquet J, Jeffery PK, Busse WW, Johnson M, et al. 2000. Asthma: From bronchoconstriction to airway inflammation and remodeling. Am J Respir Crit Care Med. 161:1720–1745.PubMedGoogle Scholar
  16. Braun-Fahrlander C, Riedler J, Herz U, Eder W, et al. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. NEJM. 347:869–877.PubMedGoogle Scholar
  17. Burrows B, Martinez FD, Halonen M, Barbee RA, et al. 1989. Association of asthma with serum IgE levels and skin-test reactivity to allergens. NEJM. 320:271–277.PubMedGoogle Scholar
  18. Busse WW, Coffman RL, Gelfand EW, Kay AB, et al. 1995. Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products. Am J Respir Crit Care Med. 152:388–393.Google Scholar
  19. Busse WW, Fahy JV, Rick RB. 1998. A pilot study of the effects of an anti-IgE antibody (E25) on airway inflammation in moderate-severe asthma. Am J Respir Crit Care Med. 157:456A.Google Scholar
  20. Busse WW. 2000. Mechanisms and advances in allergic diseases. J All Clin Immunol. 105:S593–S598.Google Scholar
  21. Busse W, Kraft M. 2005. Cysteinyl leukotrienes in allergic inflammation: Strategic target for therapy. Chest. 127:1312–1326.PubMedGoogle Scholar
  22. Chen W, Hershey GKK. 2007. Signal transducer and activator of transcriptional signals in allergic disease. J All Clin Immunol. 119:529–541.Google Scholar
  23. Cherwinski HM, Schumaker JH, Brown KD, Mosmann TR. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J Exp Med. 166:1299–1244.Google Scholar
  24. Chung F. 2001. Anti-inflammatory cytokines in asthma and allergy: Interleukin 10, interleukin 12, interferon gamma. Mediators Inflamm. 10:51–59.PubMedGoogle Scholar
  25. Cohn L, Homer RJ, Niu N, Bottomly K. 1999. T helper 1 cells and interferon regulate allergic airway inflammation and mucus production. J Exp Med. 190:1309–1317.PubMedGoogle Scholar
  26. Contopoulos-Loannidis DG, Kouri LN, Loannidis JPA. 2007. Genetic predisposition to asthma and atopy. Respiration. 74:8–12.Google Scholar
  27. Corren J, Diaz-Sanchez D, Reimann J, ,Saxon A, Adelman D. 1998. Effects of anti-IgE antibody therapy on nasal reactivity to allergen and IgE synthesis in vivo. J All Clin Immunol.101:S105.Google Scholar
  28. Cosmi L, Annunziato F, Iwasaki M, Galli G, et al. 2000. CRTH2 is the most reliable marker for detection of circulating human type 2 Th2 and type 2 T cytotoxic cells in health and disease. Eur J Immunol. 30:2972–2979.PubMedGoogle Scholar
  29. Creticos PS, Schroeder JT, Hamilton RG, Balcer-Whaley SL, et al. 2006. Immunotherapy with a ragweed-toll like receptor 9 agonist vaccine for allergic rhinitis. NEJM. 355:1445–1455.PubMedGoogle Scholar
  30. Cui ZH, Joetham M, Aydintug MK, Hahn YS, et al. 2003. Reversal of allergic airway hyperactivity after long term allergen challenge depends on (gamma) (delta) T cells. Am J Respir Crit Care Med. 168:1324–1332.PubMedGoogle Scholar
  31. Davis P. 2005. Carl Prausnitz and the mysteries of allergy. Biomed Sci. December:1247.Google Scholar
  32. Demoly P, Bousquet J. 1997. Anti-IgE therapy for asthma. Am J Respir Crit Care Med. 155:1825–1827.PubMedGoogle Scholar
  33. Denburg JA. (Ed.) 1998. Allergy and Allergic Disease: The New Mechanisms and Therapeutics. Humana Press: New Jersey. ISBN: 0-89603-404-6.Google Scholar
  34. Durham SR, Walker SM, Varga EM, Jacobsen MR, et al. 1999. Long-term clinical efficacy of grass pollen immunotherapy. NEJM. 341:468–475.PubMedGoogle Scholar
  35. Elias JA. 2000. Airway remodeling in asthma. Am J Respir Crit Care Med. 161:S168–S171.PubMedGoogle Scholar
  36. Emanuel MB. 1988. Hay fever, a post industrial revolution epidemic: A History of its growth during the 19th century. Clin Allergy. 18:295–304.PubMedGoogle Scholar
  37. Erpenbeck VJ, Hohlfeld JM, Discher M, Krentel H, et al. 2003. Increased messenger RNA expression of C-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. Chest. 123:370S–371S.Google Scholar
  38. Fahey JV, Fleming HE, Wong HH, Liu J, et al. 1997. The effect of an anti-IgE monoclonal antibody on the early-and late-phase responses to allergen inhalation in asthmatic subjects. Am J Respir Crit Care Med. 155:1828–1834.Google Scholar
  39. Fireman P. 2003. Understanding asthma pathophysiology. Allergy Asthma Proc. 24:79–83.PubMedGoogle Scholar
  40. Freeman J. 1911. Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine. Lancet. 2:814–817.Google Scholar
  41. Freeman J. 1914. Vaccination against hay fever: Report of results during the first three years. Lancet. 1:1178–1180.Google Scholar
  42. Frew AJ, Corrigan CJ, Maestrelli P, Tsai JJ, et al. 1989. T lymphocytes in allergen-induced late-phase reaction and asthma. Int Arch Allergy Appl Immunol. 88:63–67.PubMedGoogle Scholar
  43. Frew AJ, Kay AB. 1990. Eosinophils and T-lymphocytes in late phase allergic reactions. J All Clin Immunol. 85:533–539.Google Scholar
  44. Galli SJ. 1993. New concepts about the mast cells. NEJM. 328:257–265.PubMedGoogle Scholar
  45. Gangur V, Oppenheim JJ. 2000. Are chemokines essential or secondary participants in allergic responses? Ann All Asthma Immunol. 84:569–581.Google Scholar
  46. Gell PGH, Coombs RRA. (Eds.). 1963. Clinical Aspects of Immunology. 1st Ed., Blackwell, Oxford, England.Google Scholar
  47. Gould HJ, Sutton BJ, Beavil AJ, Beavil RL, et al. 2003. The biology of IgE and the basis of allergic disease. Ann Rev Immunol. 21:579–628.Google Scholar
  48. Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, et al. 2006. Mechanisms of disease: The hygiene hypothesis revisited. Nat Clin Prct Gastroenterol Hepatol. 3:275–284.Google Scholar
  49. Hang LW, Hsia TC, Chen WC, Chen HY, et al. 2003. Tap 1 Gene Acc1 polymorphism is associated with atopic bronchial asthma. J Clin Lab Anal. 17:57–60.PubMedGoogle Scholar
  50. Hauber HP, Bergeron C, Hamid Q. 2004. IL-9 in allergic inflammation. Int Arch All Immunol. 134:79–87.Google Scholar
  51. Hawrylowicz CM, O’Garra A. 2005. Potential role of interleukin-10 secreting regulatory T cells in allergy and asthma. Nat Rev Immunol. 5:271–283.PubMedGoogle Scholar
  52. Hennino A, Vocanson M, Toussiant Y, Rodet K, et al. 2007. Skin-infiltrating CD8+ T cells initiate atopic dermatitis lesions. J Immunol. 178:5571–5577.PubMedGoogle Scholar
  53. Hollingsworth JW, Whitehead GS, Lin K, Nakano H, et al. 2006. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol. 176:5856–5862.PubMedGoogle Scholar
  54. Howarth PH, Salagean M, Dokic D. 2000. Allergic rhinitis: Not purely a histamine-related disease. Allergy, 55: 7–16.PubMedGoogle Scholar
  55. Illig T, Wjst M. 2002. Genetics of asthma and related phenotypes. Paed. Respir Rev. 3:47–51.Google Scholar
  56. Ishizaka K, Ishizaka T. 1967. Identification of gamma-E-antibodies as carrier of reaginic activity. J Immunol. 99:1187–1198.PubMedGoogle Scholar
  57. Ishizaka K, Ishizaka T, Terry WD. 1967. Antigenic structure of gamma-E-globulin and reaginic antibody. J Immunol. 99:849–858.PubMedGoogle Scholar
  58. Johansson SGO. 1967. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet. 2:951–953.PubMedGoogle Scholar
  59. Johansson SGO, Bennich H, Wide L. 1968. A new class of immunoglobulins in human serum. Immunology,. 14: 265–272.PubMedGoogle Scholar
  60. Joos GF, DeSwert KO, Schelfhout V, Pauwels RA. 2003. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann NY Acad Sci. 992:218–230.PubMedGoogle Scholar
  61. Kaliner M, Lemanske R. 1984. Inflammatory responses to mast cell granules. Fed Proc. 43:2846–2851.PubMedGoogle Scholar
  62. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, et al. 2003. Probiotics and prevention of atopic disease: 4 year follow up of a randomized placebo controlled trial. Lancet. 361:1869–1871.PubMedGoogle Scholar
  63. Karlsson MR, Rugtveit J, Brandtzaeg P. 2004. Allergen responsive CD4+ CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med. 12:1679–1688.Google Scholar
  64. Kaufman HS, Frick OL. 1976. The development of allergy in infants of allergic parents: A prospective study concerning the role of heredity. Ann Allergy. 37:410–415.PubMedGoogle Scholar
  65. Kay AB. 2001a. Allergy and allergic diseases – First of two parts. NEJM. 344:30–37.Google Scholar
  66. Kay AB. 2001b. Allergy and allergic diseases – Second of two parts. NEJM. 344:109–113.Google Scholar
  67. Kozyrskyj AL, Ernst P, Becker AB. 2007. Increased risk of childhood asthma from antibiotic use in early life. Chest. 131:1753–1759.PubMedGoogle Scholar
  68. Lasley MV. 1999. Allergic disease prevention and risk factor identification. Immunol. All. Clin North Am. 19:149–159.Google Scholar
  69. Lauener RP, birchler T, Adamski J, Braun-Fahrlander C, et al. 2002. Expression of CD14 and Toll-like receptor 2 in farmer’s children. Lancet. 36:465–466.Google Scholar
  70. Lawlor GJ, Fischer TJ, Adelman DC, eds. 1995. Manual of Allergy and Immunology. 3rd Ed. Lippincott-Raven, Philadelphia, PA.Google Scholar
  71. Lichtenstein LM, Ishizaka K, Norman PS, Sobotka AD, et al. 1973. IgE antibody measurements in ragweed hay fever relationship to clinical severity and the results of immunotherapy. J Clin Inv. 52:472–482.Google Scholar
  72. Luckacs NW. 2001. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol. 1:108–116.Google Scholar
  73. Martinez FD. 2007. Gene-environment interaction in asthma: With apologies t William of Ockham. Proc Am Thorac Soc. 4:26–31.PubMedGoogle Scholar
  74. Miyahara N, Takeda K, Kodama T, Joetham A, et al. 2004. Contribution of antigen-primed CD8+ T cells to the development of airway hyper-responsiveness and inflammation is associated with IL-13. J Immunol. 172:2549–2558.PubMedGoogle Scholar
  75. Mosmann TR, Coffman R. 1989. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol. 7:145–173.Google Scholar
  76. Nagata K, Tanaka K, Ogawa K, Kemmostu K, et al. 1999. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol. 162:1278–1286.PubMedGoogle Scholar
  77. Nakajima H, Takatsu K. 2007. Role of cytokines in allergic airway inflammation. Int Arch All Immunol. 142:265–273.Google Scholar
  78. Nassenstein C, Braun A, Erpenbeck A, Lommatzsch M, et al. 2003. The neurotrophins nerve growth factors, brain derived neurotrophic factor, neurotrophin 3 and neurotrophin 4 are survival and activation factors for eosinophils in patients with allergic bronchial asthma. J Exp Med. 198:455–467.PubMedGoogle Scholar
  79. Nassenstein C, Braun A, Nockher WA, Renz H. 2005. Neurotrophin effects of eosinophils in allergic inflammation. Curr All Asthma Rep. 5:204–211.Google Scholar
  80. Ngoc PL, Gold DR, Tzianbos AO, Weiss ST, et al. 2005. Cytokines, allergy and asthma. Curr Opin All Clin Immunol. 5:161–166.Google Scholar
  81. Nigo YI, Yamashita M, Hirahara K, Shinnakasu R. 2006. Regulation of allergic airway inflammation through the Toll-like receptor 4-mediated modification of mast cell function. PNAS USA. 103:2286–2291.PubMedGoogle Scholar
  82. Nockher WA, Renz H. 2006. Neurotrophins and asthma: Novel insight into neuroimmune interaction. J All Clin Immunol. 117:67–71.Google Scholar
  83. Noon L. 1911. Prophylactic inoculation against hayfever. Lancet. 1:1572–1573.Google Scholar
  84. Norman PS, Ohman JL, Long AA, Creticos PS, et al. 1996. Treatment of cat allergy with T-cell reactive peptides. Am J Respir. Crit Care Med. 154:1623–1628.Google Scholar
  85. O’Byrne PM. 2006. Cytokines and their antagonists for the treatment of asthma. Chest. 130:244–250.PubMedGoogle Scholar
  86. Oliver PM, Cao X, Worthen GS, Shi P, et al. 2006. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity. 25:929–940.PubMedGoogle Scholar
  87. Ono S. 2000. Molecular genetics of allergic diseases. Ann Rev Immunol. 18:347–366.Google Scholar
  88. Panina-Bordignon P, Papi A, Mariani M, DiLucia P. 2001. The C–C chemokine receptors and CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Inv. 107:1357–1364.Google Scholar
  89. Passalacqua G. 2007. Allergic rhinitis and its impact on asthma update. Allergen immunotherapy. J All Clin Immunol. 119:881–891.Google Scholar
  90. Pepys J. 1994. “Atopy;” a study in definition. Allergy. 49:397–399.Google Scholar
  91. Pernis AB, Rothman PB. 2002. JAK-STAT signaling in asthma. J Clin Inv. 109:1279–1283.Google Scholar
  92. Platts-Mills TA. 2001. The role of immunoglobulin E in allergy and asthma. Am J Respir Crit Care Med. 164:S1–S5.PubMedGoogle Scholar
  93. Prussin C, Metcalfe DD. 2003. IgE, mast cells, basophils and eosinophils. J All Clin Immunol. 111:5486–5494.Google Scholar
  94. Racila DM, Kline JN. 2005. Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment. J All Clin Immunol. 116:1202–1205.Google Scholar
  95. Rajan TV. 2003. The Gell-Coombs classification of hypersensitivity reactions: A reinterpretation. Trends Immunol. 24:376–379.PubMedGoogle Scholar
  96. Ray A, Cohn L. 1999. TH2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation. J Clin Inv. 104:995–1006.Google Scholar
  97. Reynolds C, Ozerovitch L, Wilsen R, Altmann D, et al. 2007. Toll-like receptors 2 and 4 and innate immunity in neutrophilic asthma and idiopathic bronchiectasis. Thorax. 62:279.PubMedGoogle Scholar
  98. Robertson DG, Kerigan AT, Hargreave FE, Chalmers R, et al. 1974. Late asthmatic responses induced by ragweed pollen allergen. J All Clin Immunol. 54:244–254.Google Scholar
  99. Rochlitzer S, Nassenstein C, Braun A. 2006. The contribution of neurotrophins to the pathogenesis of allergic asthma. Biochem Soc Trans. 34:594–599.PubMedGoogle Scholar
  100. Romagnani S. 1994. Lymphokine production by human T cells in disease states. Ann Rev Immunol. 12:227–257.Google Scholar
  101. Romagnani S. 2000. The roles of lymphocytes in allergic disease. J All Clin Immunol. 105:399–408.Google Scholar
  102. Romagnani S. 2002. Cytokines and chemoattractants in allergic inflammation. Mol Immunol. 38:881–885.PubMedGoogle Scholar
  103. Rothenberg ME. 1998. Eosinophilia. NEJM. 338:1592–1600.PubMedGoogle Scholar
  104. Schaub Bm, Lauener R, Von ME. 2006. The many faces of the hygiene hypothesis. J All Clin Immunol. 117:969–977.Google Scholar
  105. Schmitz N, Kurrer M, Kopf M. 2003. The IL-1 receptor 1 is critical for TH2 cell type airway immune responses in a mild but not in more severe asthma model. Eur J Immunol. 33:991–1000.PubMedGoogle Scholar
  106. Schnare M, Barton GM, Holt AC, Taked K, et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat Immunol. 2:947–950.PubMedGoogle Scholar
  107. Schoenwetter WF. 2000. Allergic rhinitis: Epidemiology and natural history. Allergy Asthma Proc. 21:1–6.PubMedGoogle Scholar
  108. Sel S. Wegmann M. Sel S, Bauer S, et al. 2007. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and Il-10. J Immunol. 178:7805–7813.PubMedGoogle Scholar
  109. Seneviratne SL, Jones L, King AS, Black A, et al. 2002. Allergen specific CD8+ T cells in atopic disease. J Clin Inv. 110:P1283–1291.Google Scholar
  110. Serafin WE, Austen KF. 1987. Mediators of immediate hypersensitivity reactions. NEJM. 317:30–34.PubMedGoogle Scholar
  111. Simpson JL, Grissell TV, Douwes J, Scott RJ, et al. 2007. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax. 62:211–218.PubMedGoogle Scholar
  112. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. 1976. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Inv. 58:408–420.Google Scholar
  113. Spitz E, Gelfand EW, Sheffer AL, Austen KF. 1972. Serum IgE in clinical immunology and allergy. J All Clin Immunol. 49:337–347.Google Scholar
  114. Strachan DP. 1989. Hay fever, hygiene and household size. Brit Med J. 299:1259–1260.PubMedGoogle Scholar
  115. Strachan DP. 2000a. Family size, infection and atopy: The first decade of the “hygiene hypothesis.” Thorax. 55:S2–S10.Google Scholar
  116. Strachan DP. 2000b. Family size, infection and atopy: The first decade of the “hygiene hypothesis.” Thorax. 1:S2–S10.Google Scholar
  117. Strachan DP, Wong HJ, Spector TD. 2001. Concordance and interrelationship of atopic diseases and markers of allergic sensitization among adult female twins. J All Clin Immunol. 108:901–907.Google Scholar
  118. Takhar P, Smurthwaite L, Coker HA, Fear DJ, et al. 2005. Allergen derives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol. 174:5024–5032.PubMedGoogle Scholar
  119. Umetuse DT, DeKruff RH. 2006. The regulation of allergy and asthma. Immunol Rev. 212:238–255.Google Scholar
  120. Undem BJ, Carr MJ. 2002. The role of nerves in asthma. Curr All Asthma Rep. 2:159–165.Google Scholar
  121. Van Hove CL, Maes T, Joos GF, Tournoy KG. 2007. Prolonged inhaled allergen exposure can induce persistent tolerance. Am J Respir Cell Mol Biol. 36:573–584.PubMedGoogle Scholar
  122. Varney VA, Gaga M, Frew AJ, Eber VR, et al. 1991. Usefulness of immunotherapy in patients with severe summer hayfever uncontrolled by anti-allergic drugs. Br Med J. 302:265–269.Google Scholar
  123. Von Mutius E. 2002. Environmental factors influencing the development of progression of pediatric asthma. J All Clin Immunol. 109:525–532.Google Scholar
  124. Wagner R. 1968. Clemens Von Priquet: His Life and Work. The John Hopkins Press, Baltimore, MD.Google Scholar
  125. Wang YH, Ito T, Wang YH, Homey B, et al. 2006. Maintenance and polarization of human Th2 central memory T cells by thymic stromal lymphopoietin activated dendritic cells. Immunity. 24:827–838.PubMedGoogle Scholar
  126. Weber RW. 1997. Immunotherapy with allergens. JAMA. 278:1881–1887.PubMedGoogle Scholar
  127. Weiss ST. 2002. Eat dirt – The hygiene hypothesis and allergic diseases. 347:930–931.Google Scholar
  128. Widdicombe JG. 2003. Overview of neural pathways in allergy and asthma. Pulm Pharmacol Ther. 16:23–30.PubMedGoogle Scholar
  129. Wills-Karp M. 2001. IL-12/IL-13 axis in allergic asthma. J All Clin Immunol. 107:9–18.Google Scholar
  130. Woodfolk JA. 2007. T-cell responses to allergens. J All Clin Immunol. 119:280–294.Google Scholar
  131. Zuany-Amorim C, Ruffie C, Haile S, Vargaftig BB, et al. 1998. Requirement of γδ T cells in allergic airway inflammation. Science. 280:1265–1267.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Creighton University Medical CenterOmahaUSA

Personalised recommendations